Role of Dopamine Receptor Agonists in the Treatment of Restless Legs Syndrome

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.1, 2004-01, pp. : 27-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dopamine agonists for the treatment of restless legs syndrome

By Fulda Stephany Wetter Thomas C

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2655-2666

Informa Healthcare

Access to resources Recommend Favorite

Dopamine receptor agonists: Worsening of restless legs syndrome, with nocturnal eating and weight gain in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1260, 2009-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Ropinirole treatment for restless legs syndrome

By Chitnis Shilpa

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 5, 2008-05 ,pp. : 655-664

Informa Healthcare

Access to resources Recommend Favorite

Ropinirole: For the Treatment of Restless Legs Syndrome

By Susan M. Cheer Lynne M. Bang Gillian M. Keating

CNS Drugs, Vol. 18, Iss. 11, 2004-01 ,pp. : 747-754

Adis International

Access to resources Recommend Favorite

Aetiology and Treatment of Restless Legs Syndrome

By Collado-Seidel V. Winkelmann J. Trenkwalder C.

CNS Drugs, Vol. 12, Iss. 1, 1999-07 ,pp. : 9-20

Adis International

Access to resources Recommend Favorite